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There is little question that the ipsilateral auto-
genous greater saphenous vein is the preferred con-
duit for infrainguinal reconstructions.1-3 However,
this vein (much valued by both cardiac and vascular
surgeons) is a limited resource. Alternatively, other
sources of autogenous vein may be used for arterial
bypass grafts. These include the residual greater
saphenous vein, the lesser saphenous vein, the arm
veins, and, rarely, the superficial femoral vein.4-6
When even these optional conduit choices are
unavailable, then other strategies must be used to
achieve limb salvage, including the use of alternative
inflow sources, the sequential type bypass grafting,
the use of homologous preserved vein, or the use of
prosthetic bypass grafts.
Poor long-term outcomes can be anticipated
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Purpose: The long-term patency for infrapopliteal bypass grafting with prosthetic mate-
rial is less than optimal. Our experience demonstrates a 40% patency at 2 years for these
grafts. Several adjuvant techniques have been developed to improve patency rates, two
of which are a remote distal arteriovenous fistula and the creation of a distal vein cuff.
This study summarizes our experience with these two techniques.
Methods: Between 1987 and 1998, 107 bypass graftings were performed to the below-
knee popliteal or tibial vessels with the use of polytetrafluoroethylene. One group (48
bypass grafts) had polytetrafluoroethylene with adjuvant distal arteriovenous fistula
(DAVF), and a second group (59 bypass grafts) was reconstructed with a distal vein cuff
(DVC). The type of bypass grafting that was performed was based on surgeon experi-
ence and preference. Indications and demographics were similar in the two groups. All
patients underwent the operation for limb-threatening ischemia, including gangrene
(DAVF, 23%; DVC, 9%), ulceration (DAVF, 27%; DVC, 51%), and rest pain (DAVF,
50%; DVC, 40%).
Results: The primary patency rate was 48% and 38% at 3 years for DAVF and DVC,
respectively. Secondary patency was 48% and 47% at 3 years, with limb salvage rates of
76% and 92% for DAVF and DVC, respectively (P < .05). Attempted thrombectomy
without continuation of patency was undertaken in two patients with a failed DAVF.
Attempts at restoration after thrombosis were made in eight patients with failed DVCs.
Five patients underwent thrombectomy, of which four procedures were successful. Three
patients had thrombolytic therapy, and two of these remained patent.
Conclusion: Adjuvant techniques, including DAVF and DVC, produce acceptable long-
term patency and limb salvage rates in bypass grafts performed to the below-knee
popliteal and tibial vessels. This study suggests that DVCs may offer improved limb sal-
vage rates and a greater opportunity for revision when bypass graft failure occurs. (J Vasc
Surg 2000;31:696-701.)
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with prosthetic bypass graftings to these distal ves-
sels.7 Attempts to improve graft patency and limb
salvage when faced with a lack of usable autogenous
vein have prompted efforts such as the use of distal
arteriovenous fistulae8,9 and the placement of a dis-
tal vein cuff or patch10-12 or some combination of
the two.13 Our experience with direct prosthetic
without technical enhancements demonstrates a 40%
patency at 2 years. In this report, we will compare
our experience with distal arteriovenous fistulae and
venous cuffs to attempt to improve prosthetic bypass
graft patency and limb salvage in patients with limb-
threatening ischemia.
METHODS
The records of all patients who underwent infra-
geniculate arterial reconstruction for limb salvage
indications between 1987 and 1998 were reviewed.
Before the operation, all patients underwent arterial
imaging with either conventional angiography, car-
bon dioxide angiography, or magnetic resonance
angiography. The status of available vein was evalu-
ated by ultrasound scanning before the operation.
Autogenous venous conduits were preferentially
used unless after duplex scanning they were consid-
ered too small, thrombosed, or of inadequate
length. Bypass grafts were preferentially created with
either a single length of vein or were spliced. All
patients had prior arterial reconstructions. In
patients with insufficient usable autogenous vein,
distal bypass graftings were performed with polyte-
trafluoroethylene (PTFE) grafts coupled with a
remote distal arteriovenous fistula (DAVF) or with a
distal vein cuff (DVC). During the study period, a
total of 63 bypass grafts were performed without an
adjunctive procedure. DAVF was the technique used
primarily between 1987 and 1994. DVC was the
technique used from 1994 through 1998. Selection
of the type of bypass graft was not based on any
patient criteria but on physician preference. Patient
demographics and the indications for operation are
shown in Tables I and II.
The technique for the creation of the prosthetic
bypass graft with a remote arteriovenous fistula has
been previously described.9 In brief, this involves
standard exposure of the respective inflow and out-
flow arteries. Often the common femoral artery
could not be used because of previous bypass graft
surgery. After heparin is given intravenously (30
units/kg), a 6-mm thin-walled PTFE conduit is tun-
neled between the two exposures and sewn end-to-
side to the distal arteries with a 6-0 or 7-0
polypropylene suture. A 5-mm side-to-side arterio-
venous fistula is then fashioned between the outflow
artery and its paired vein approximately 5 to 10 cm
distal to the PTFE anastomosis with a 7-0 prolene
suture. By placing the fistula at this point, we hope
to increase the flow in the intervening segment and
improve collateral flow in the leg. The clamps are
then released, and flow through the bypass graft, fis-
tula, and intervening arterial segment is evaluated
with a Doppler flow probe.
The technique for the venous boot is described
by Wolfe and Tyrell.12 Briefly, the proximal end of a
6-mm PTFE graft is anastomosed to the in-flow
artery. The graft is tunneled directly to the distal
exposure. A 4-cm piece of vein is then harvested.
Segments of cephalic, basilic, or saphenous (greater,
lesser, accessory) vein were used to create the vein
cuffs. The anastomosis of the vein to the artery is
performed to an arteriotomy at least 2 cm in length.
The depth of the boot is kept to approximately 3 to
4 mm.
After the operation, all patients underwent anti-
coagulation with heparin to achieve a partial throm-
boplastin time of 1.5 to 2 time-control levels. They
are subsequently placed on warfarin (Coumadin) to
maintain an international normalized ratio of 2.0 to
3.0. Patient compliance with Coumadin was approx-
imately 60% in the DAVF group. All except four
patients were compliant with Coumadin therapy in
the vein cuff group. These four patients all experi-
enced bypass failure in association with stopping their
Coumadin. After discharge patients were followed up
at 3-month intervals with clinical examination, pulse
volume recordings, and duplex scanning.
Table II. Operative indications
DAVF DVC P value
Claudication (n; %) 0 (0) 0 (0) NS
Gangrene (n; %) 11 (23) 6 (10)* NS
Ulcer (n; %) 13 (27) 32 (55)† < .05
Rest pain (n; %) 24 (50) 21 (35) NS
*P = .06.
†P = .0424.
Table I. Patient demographics
DAFV DVC P value
Male (n; %) 25 (56) 35 (58) NS
Female (n; %) 20 (44) 25 (42) NS
Diabetics (n; %) 20 (44) 32 (53) NS
Smokers (n; %) 16 (36) 26 (43) NS
Mean age (y) 70 69 NS
Age range (y) 51-89 40-91
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RESULTS
Forty-eight distal PTFE bypass grafts with remote
autogenous arteriovenous fistulae were constructed in
45 patients. Fifty-nine patients underwent PTFE
bypass grafting with construction of a DVC. The
inflow and outflow vessels used are shown in Tables III
and IV. We noticed no difference in patency when the
grafts were compared by outflow artery. Although the
numbers are too small to allow statistical inference,
bypass graft performed to the dorsalis pedis artery
faired the worst, with none patent beyond 6 months in
either group. All deaths were cardiac in origin (myocar-
dial infarction and not related to congestive heart fail-
ure from the fistula). The operative mortality rate was
6.7% (3/46 patients) in the DAVF group and 1.6%
(1/59 patients) in the DVC group. Causes of periop-
erative morbidity are shown in Table V. Primary and
secondary graft patencies are given in Tables VI and
VII. Primary patencies for the DAVF and DVC groups
were 87% and 96% at 30 days and 48% and 38% at 3
years, respectively. Secondary patency was 48% and 47%
at 3 years for DAVF and DVC groups, respectively. In
the DAVF group, there were four bypass graft revi-
sions: two involving outflow artery revisions and two
involving graft thrombectomy. One patient who under-
went thrombectomy and one patient who underwent
outflow graft revision went on to secondary patency.
Five patients in the DVC group underwent attempted
thrombectomy, four of which were successful. Two
patients required revision after thrombectomy. Three
patients underwent lytic therapy, and two of these
patients went on to continued patency. One patient
who underwent successful lytic therapy eventually
required outflow graft revision. Patients who required
graft revision had hyperplastic lesions at the PTFE vein
cuff anastomosis. These thromboses occurred between
6 months and 1 year. Limb salvage (Table VIII) for the
two groups at 2 years was 76% and 92% for DAVF and
DVC, respectively (P < .05).
DISCUSSION
The suboptimal patency achieved with the use of
prosthetic materials alone in femorocrural bypass
grafts has been attributed to various factors that
include increased thrombogenicity of synthetic
material and technical error.14 More important,
these procedures seem to be associated with acceler-
ated intimal hyperplasia at the distal native run-off
vessel.15 Often, patients who require the use of pros-
thetic material have had previous bypass graft and
are devoid of autogenous vein. Thus the surgeon is
often faced with the challenge of a distal arterial
reconstruction, often to a disadvantaged outflow
bed with a thrombogenic prosthetic material.
Extremely low patency rates (of 30% or less) report-
ed for the use of PTFE grafts for femoroin-
frapopliteal bypass graft have generated controversy
concerning the choice between vascular reconstruc-
tion and primary amputation in the absence of
autologous vein. Several techniques have been
devised to improve prosthetic graft patency, includ-
ing anticoagulation,16 vein patches,14 venous
boots,10-12,17,18 and the creation of arteriovenous
fistulae to help in this situation.8,9,13
Arteriovenous fistulae constructed at or near the
distal anastomosis have been used to improve the
patency in reconstructions to the infrageniculate
level.8,19,20 Improvement in the patency of these
grafts with the addition of these fistula is attributed
to the theory that the fistula will reduce the resis-
tance to flow and thereby increase the flow through
the prosthetic graft. The increase in graft flow vol-
ume and velocity may overcome the thrombotic
Table III. Inflow artery
DAVF DVC P value
Graft/iliac (n; %) 13 (27) 16 (25) NS
Common femoral (n; %) 27 (56) 46 (71)* < .05
Superficial femoral (n; %) 3 (7) 2 (3) NS
Profunda femoral (n; %) 5 (10) 1 (1) NS
*P = .02.
Table IV. Outflow artery
DAVF DVC P value
Below-knee popliteal (n; %) 5 (10) 7 (12) NS
Proximal anterior tibial (n; %) 12 (25) 7 (12) NS
Distal anterior tibial (n; %) 2 (4) 7 (12) NS
Dorsalis pedis (n; %) 2 (4) 1 (1) NS
Proximal posterior tibial (n; %) 6 (13) 8 (14) NS
Distal posterior tibial (n; %) 5 (10) 6 (10) NS
Proximal peroneal (n; %) 14 (27) 16 (27) NS
Distal peroneal (n; %) 2 (4) 7 (12) NS
Proximal, Proximal one half of the artery; Distal, distal one half
of the artery.
Table V. Perioperative morbidity/mortality rates
DAVF DVC P value
Mortality (n; %) 3 (6.7) 1 (1.6) NS
Morbidity (n; %)
Nonfatal cardiac 2 (4) 1 (1.6) NS
Graft infection 2 (4) 6 (9) NS
Wound infection 2 (4) 3 (5) NS
Bleeding 1 (2) 1 (2) NS
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threshold velocity of the prosthetic material and thus
increase its patency. An extensive experience with
these reconstructions has been reported by Dardik
et al,8 who use glutaraldehyde stabilized human
umbilical vein grafts with a common ostium-type
arteriovenous fistula. Current reported patency rates
for these grafts are 61% at 3 years. We have previ-
ously reported our early experience with DAVF.9
Currently, we have achieved patencies of 48% at 2
years, with a limb salvage rate of 76%. Ascer et al13
have reported their results with a unique type of
arteriovenous fistula that combines elements of
DAVF and a vein cuff. The procedure is performed
by anastomosing the cephalad portion of the ligated
vena concomitant to the runoff artery and then pig-
gybacking the graft on top of the vein. The authors
believe that the interposed vein acts not only as a fis-
tula for venous decompression but also serves as a
vein cuff for improved compliance and perhaps
other mechanisms to improve graft patency.
Cumulative patency results reported for these grafts
were 62% at 3 years, with limb salvage rates of 77%.
Siegman21 first advocated the use of a venous
cuff in 1979 to facilitate the performance of anasto-
moses to calcified arteries. Miller et al22 described a
vein cuff, and Taylor et al14 described a vein patch to
Table VI. Primary patency for DAVF and DVC
Interval Grafts at Occlusions / Interval Cumulative
(mo) risk (n) revisions (n) patency patency SE
DAVF
0-1 47 6 0.864 1.00 0
2-12 35 5 0.846 0.864 5.1
13-24 25 8 0.652 0.731 5.5
25-36 13 0 1.00 0.477 7.6
DVC
0-1 59 2 0.962 1.00 0
2-12 43 19 0.472 0.962 2.6
13-24 10 1 0.833 0.454 8.0
25-36 1 0 1.00 0.378 9.6
Table VIII. Limb salvage for DAVF and DVC
Interval Limbs at Interval Cumulative
(mo) risk (n) Amputations (n) salvage salvage SE
DAVF
0-1 47 3 0.931 0.931 0
2-12 36 3 0.906 0.844 3.8
13-24 25 2 0.900 0.759 5.9
25-36 13 0 1.000 0.759 7.1
DVC
0-1 59 3 0.949 0.949 0
2-12 49 1 0.968 0.918 3.1
13-24 12 0 1.00 0.918 4.3
25-36 1 0 1.00 0.918 11.0
Table VII. Secondary patency for DAVF and DVC
Interval Grafts at Occlusions / Interval Cumulative 
(mo) risk (n) revisions (n) patency patency SE
DAVF
0-1 47 6 0.864 1.00 0
2-12 35 5 0.846 0.864 5.1
13-24 25 8 0.652 0.731 7.0
25-36 13 0 1.00 0.477 8.5
DVC
0-1 59 1 0.981 1.00 0
2-12 44 19 0.479 0.981 1.9
13-24 10 0 1.000 0.470 8.1
25-36 1 0 1.000 0.470 9.3
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improve the results of PTFE bypass grafts to distal
arteries. Wolfe and Tyrell12 incorporated both the
advantages of the cuff and the patch techniques by
creating a boot-shaped reservoir to which the pros-
thetic graft is anastomosed. Theoretically, a vein cuff
interposed between a small compliant artery and a
stiff noncompliant graft minimizes the compliance
mismatch between the two and may reduce mechan-
ical injury, although investigations have questioned
the validity of this theory.23 The vein may also sim-
ply expand the distal anastomosis so that the area of
intimal hyperplasia encroaches on a wider lumen,
making its amount less critical. It has also been sug-
gested that perhaps the venous endothelium confers
a beneficial physiologic effect through the inhibition
of intimal hyperplasia. Several groups have reported
good patency results using this technique.
Stonebridge et al18 reported a 59% patency rate at 2
years for below-knee popliteal bypass grafts with
PTFE and a vein cuff and a limb salvage rate of 84%.
Similarly, Raptis and Miller10 and Neville et al11
demonstrated superior results for infrapoliteal bypass
grafts with vein cuffs as opposed to PTFE alone.
Our results, although not as impressive as these,
demonstrated a patency and limb salvage of 47% and
92% at 2 years, respectively. We recognize, however,
that when comparing our DAVF and our limb sal-
vage rates that there was a predominance of patients
with ulcers rather than gangrene in the DVC group,
which may affect the higher limb salvage.
We and others10 have noticed that in grafts that
have failed, the cuff often remains patent when the
PTFE graft had occluded. The fact that the cuff
remains open preserves the distal run-off vessel. We
observed this in all the successfully revised grafts that
failed between 6 months and 1 year. This situation
allows either thrombolytic or surgical intervention
to salvage these grafts. In fact Raptis and Miller10
demonstrated that it is possible to reuse the pre-
existing cuff in 51% of cases.
In our series, four of five grafts underwent suc-
cessful thrombectomy, and two of three grafts
underwent successful lytic therapy. Most of these
grafts that were salvaged were later in the series.
Early in this series, we did not attempt salvage of
many of these grafts. Given the reasons stated earli-
er, we now have adopted a more aggressive approach
in attempts to salvage these grafts. Therefore all
failed vein cuff bypass grafts now undergo either
lytic therapy or thrombectomy and revision, if possi-
ble. Additionally, we have observed that patency of
the arteriovenous fistula is required for graft paten-
cy. Our duplex data demonstrated that graft occlu-
sion occurred in eight patients after detectable fistu-
la occlusion. Although no new fistulae were created
after occlusion, one may theorize that the creation
of a new fistula may have allowed continued paten-
cy. Few attempts were made at graft salvage, and our
results in patients with DAVF is limited. The salvage
of these grafts does not occur with the same fre-
quency as in patients with vein cuffs. Four DAVF
bypass grafts underwent revision, two for inflow
revision and two for graft thrombectomy. Two of
these four patients went on to long-term patency.
No attempts were made at revision of the fistula
when they had occluded.
CONCLUSION
There is no question that an aggressive policy
toward limb salvage will often require the use of
prosthetic materials as autogenous vein becomes a
less available resource. Our results indicate that dis-
tal bypass grafting performed with PTFE either with
a DAVF or with a vein cuff produces acceptable
patency and limb salvage rates. This allows for the
salvage of the ischemic limb despite lower patency
rates than autogenous reconstruction. At our insti-
tution, we currently prefer the vein cuff technique in
patients with limb-threatening ischemia and inade-
quate venous conduit; we feel it is technically easier
to perform and may offer some advantage over the
DAVF when these grafts occlude and attempts are
made at graft salvage.
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